NaveniFlex control kit Reference: 60029 Control kit to identify positive signals in proximity ligation assays. Use together with NaveniFlex Cell/Tissue/Bright MR.
Zolbetuximab Reference: HY-P99058 Zolbetuximab (IMAB362) is a monoclonal antibody targeting Claudin-18.2. Zolbetuximab mediates specific killing of Claudin-18.2-positive cells through immune effector mechanisms. Zolbetuximab can be used for the research of gastrointestinal adenocarcinomas and pancreatic tumors.
Naveni PD1/PD-L1 HRP Reference: 60033 Visualize the interaction of PD1 and PD-L1 in situ. The kit includes primary Navenibodies specific to PD1 and PD-L1, and all other reagents needed to run the assay. Chromogenic detection and bright-field read-out
Human IgG4 kappa, Isotype Control Reference: HY-P99003 Human IgG4 kappa, Isotype Control, a human monoclonal antibody, is an isotype control for human IgG4κ antibody.
Naveni PD1/PD-L1 Atto647N Reference: 60034 Visualize the interaction of PD1 and PD-L1 in situ. The kit includes primary Navenibodies specific to PD1 and PD-L1, and all other reagents needed to run the assay. Fluorescence readout, possible to combine with co-staining.
Vesencumab Reference: HY-P99386 Vesencumab (MNRP-1685A) is IG1 antibody against neuropilin-1 (NRP-1). Vesencumab binds to NRP-1 and prevents the subsequent coupling of NRP-1 to VEGFR-2. Vesencumab has anti-angiogenic and anti-neoplastic activities. Vesencumab can be used in the research of metastatic solid tumors, including ovarian cancer.
Naveni CD8/MHCI Atto647N Reference: 60035 Visualize the interaction of CD8/MHC-I in situ. The kit includes primary antibodies specific to CD8 and MHC-I, Navenibodies, and all other reagents needed to run the assay. Fluorescence readout, possible to combine with co-staining.
Burosumab Reference: HY-P9939 Burosumab is a human fibroblast growth factor 23 (FGF23) neutralizing antibody that can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia.
Naveni Bright BOND RX HRP Reference: 60031 Detect proteins, protein – protein interactions, or protein modifications with Naveni® in situ technology using BOND RX/RXm Fully Automated Research Stainer. The kit should be used with the user’s primary antibodies of choice (raised in mouse and rabbit).
Citatuzumab bogatox Reference: HY-P99282 Citatuzumab bogatox (VB6-845) is recombinant immunotoxin that composed of Fab fragment of humanized antibody targeting EpCAM and a modified cytotoxin bouganin. Citatuzumab bogatox binds to and selectively induces apoptosis in EpCAM-positive cell lines and shows good activity in EpCAM-positive human tumour xenograft models.
Naveni PD1 PD-L1 BOND RX HRP Reference: 60032 Visualize the interaction of PD1/PD-L1 in situ using BOND RX/RXm Fully Automated Research Stainer.
Utomilumab Reference: HY-P99056 Utomilumab (PF 05082566) is a fully human IgG2 mAb agonist of the T-cell costimulatory receptor 4-1BB/CD137. Utomilumab can be used for the research of relapsed/refractory follicular lymphoma (FL) and other CD20+ non-Hodgkin lymphomas (NHL).